Altered cutaneous immune parameters in transgenic mice overexpressing viral IL-10 in the epidermis

Journal of Clinical Investigation

Volumn 111, Issue 12, 2003, Pages 1923-1931

  Ding, Wanhong ^a   Beissert, Stefan ^b   Deng, Liang ^a   Miranda, Edward ^a   Cassetty, Christopher ^a   Seiffert, Kristina ^a   Campton, Kristina L ^a   Yan, Zhengmin ^c   Murphy, George F ^d   Bluestone, Jeffrey A ^e   Granstein, Richard D ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; B7 ANTIGEN; CD86 ANTIGEN; HAPTEN; INTERLEUKIN 10; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; BCRF1 PROTEIN, HUMAN HERPESVIRUS 4; RECOMBINANT DNA; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELLULAR IMMUNITY; CONTACT ALLERGY; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; EPIDERMIS; EPIDERMIS CELL; GENE OVEREXPRESSION; IMMUNE DEFICIENCY; IMMUNE SYSTEM; IMMUNOREGULATION; LYMPH NODE; LYMPHOCYTE PROLIFERATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN; SKIN CELL; SKIN TUMOR; SPLEEN CELL; TH1 CELL; TRANSGENIC MOUSE; ULTRAVIOLET B RADIATION; ANIMAL; CONTACT DERMATITIS; CYTOLOGY; CYTOTOXICITY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETICS; HUMAN; IMMUNOLOGY; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; METABOLISM; NUCLEOTIDE SEQUENCE; T LYMPHOCYTE;

ANIMALS; BASE SEQUENCE; CYTOTOXICITY, IMMUNOLOGIC; DERMATITIS, CONTACT; DNA, RECOMBINANT; GENE EXPRESSION; HAPTENS; HERPESVIRUS 4, HUMAN; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; INTERLEUKIN-10; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MICE; MICE, TRANSGENIC; RNA, MESSENGER; SKIN; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 0041743152     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI200315722     Document Type: Article

References (38)

1. Taga, K., and Tosato, G. 1992. IL-10 inhibits human T cell proliferation and IL-2 production. J. Immunol. 148:1143-1148.
2. Del Prete, G., et al. 1993. Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J. Immunol. 150:353-360.
3. Li, L., Elliott, J.F., and Mosmann, T.R. 1994. IL-10 inhibits cytokine production, vascular leakage, and swelling during T helper 1 cell-induced delayed-type hypersensitivity. J. Immunol. 153:3967-3978.
4. Macatonia, S.E., Doherty, T.M., Knight, S.C., and O'Garra, A. 1993. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production. J. Immunol. 150:3755-3765.
5. Enk, A.H., Angeloni, V.L., Udey, M.C., and Katz, S.I. 1993. Inhibition of Langerhans cell antigen-presenting function by IL-10. A role for IL-10 in induction of tolerance. J. Immunol. 151:2390-2398.
6. de Waal Malefyt, R., et al. 1991. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174:915-924.
7. Fiorentino, D.F., Zlotnik, A., Mosmann, T.R., Howard, M., and O'Garra, A. 1991. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147:3815-3822.
8. Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science. 260:496-497.
9. Sypek, J.P., et al. 1993. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J. Exp. Med. 177:1797-1802.
10. Chen, W.F., and Zlotnik, A. 1991. IL-10: a novel cytotoxic T cell differentiation factor. J. Immunol. 147:528-534.
11. Schwarz, A., et al. 1994. In vivo effects of interleukin-10 on contact hypersensitivity and delayed-type hypersensitivity reactions. J. Invest. Dermatol. 103:211-216.
12. Baer, R., et al. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature. 310:207-211.
13. Moore, K.W., et al. 1990. Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI [erratum 1990, 250:494]. Science. 248:1230-1234.
14. Vieira, P., et al. 1991. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc. Natl. Acad. Sci. U. S. A. 88:1172-1176.
15. Fiorentino, D.F., Bond, M.W., and Mosmann, T.R. 1989. Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 170:2081-2095.
16. Go, N.F., et al. 1990. Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells. J. Exp. Med. 172:1625-1631.
17. MacNeil, I.A., Suda, T., Moore, K.W., Mosmann, T.R., and Zlotnik, A. 1990. IL-10, a novel growth cofactor for mature and immature T cells. J. Immunol. 145:4167-4173.
18. Ma, Y., et al. 1998. Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J. Immunol. 161:1516-1524.
19. Kim, K.N., et al. 2000. Viral IL-10 and soluble TNF receptor act synergistically to inhibit collagen-induced arthritis following adenovirus-mediated gene transfer. J. Immunol. 164:1576-1581.
20. Grabbe, S., et al. 1991. Tumor antigen presentation by murine epidermal cells. J. Immunol. 146:3656-3661.
21. Baker, K.W., and Habowsky, J.E. 1983. EDTA separation and ATPase Langerhans cell staining in the mouse epidermis. J. Invest. Dermatol. 80:104-107.
22. Beissert, S., et al. 1996. Impaired immunosuppressive response to ultraviolet radiation in interleukin-10-deficient mice. J. Invest. Dermatol. 107:553-557.
23. Kurimoto, I., Kitazawa, T., and Streilein, J.W. 2000. Studies of delayed systemic effects of ultraviolet B radiation (UVR) on the induction of contact hypersensitivity. II. Evidence that interleukin-10 from UVR-treated epidermis is the critical mediator. Immunology. 99:134-140.
24. Niizeki, H., and Streilein, J.W. 1997. Hapten-specific tolerance induced by acute, low-dose ultraviolet B radiation of skin is mediated via interleukin-10. J. Invest. Dermatol. 109:25-30.
25. Shreedhar, V., Giese, T., Sung, V.W., and Ullrich, S.E. 1998. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UV-induced systemic immune suppression. J. Immunol. 160:3783-3789.
26. Garssen, J., et al. 1999. UVB exposure-induced systemic modulation of Th1- and Th2-mediated immune responses. Immunology. 97:506-514.
27. Rivas, J.M., and Ullrich, S.E. 1994. The role of IL-4, IL-10, and TNF-alpha in the immune suppression induced by ultraviolet radiation. J. Leukoc. Biol. 56:769-775.
28. Yokozeki, H., et al. 1996. Functional CD86 (B7-2/B70) on cultured human Langerhans cells. J. Invest. Dermatol. 106:147-153.
29. Chang, C.H., Furue, M., and Tamaki, K. 1995. B7-1 expression of Langerhans cells is up-regulated by proinflammatory cytokines, and is downregulated by interferon-gamma or by interleukin-10. Eur. J. Immunol. 25:394-398.
30. Kawamura, T., and Furue, M. 1995. Comparative analysis of B7-1 and B7-2 expression in Langerhans cells: differential regulation by T helper type 1 and T helper type 2 cytokines. Eur. J. Immunol. 25:1913-1917.
31. Ding, L., Linsley, P.S., Huang, L.Y., Germain, R.N., and Shevach, E.M. 1993. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J. Immunol. 151:1224-1234.
32. Powrie, F., Menon, S., and Coffman, R.L. 1993. Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo. Eur. J. Immunol. 23:3043-3049.
33. Peguet-Navarro, J., et al. 1994. Interleukin-10 inhibits the primary allogeneic T cell response to human epidermal Langerhans cells. Eur. J. Immunol. 24:884-891.
34. Suzuki, T., et al. 1995. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. J. Exp. Med. 182:477-486.
35. Takayama, T., Tahara, H., and Thomson, A.W. 2001. Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth. Transplantation. 71:1334-1340.
36. Cervenak, L., et al. 2000. Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood. 96:2568-2573.
37. Cai, G., Kastelein, R.A., and Hunter, C.A. 1999. IL-10 enhances NK cell proliferation, cytotoxicity, and production of IFN-gamma when combined with IL-18. Eur. J. Immunol. 29:2658-2665.
38. Parato, K.G., et al. 2002. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of IL-10. AIDS. 16:1251-1256.